AI-Based Remote Test for Parkinson’s Disease Severity Shows Promise

By Michael Awood

September 17, 2023

People with Parkinson’s disease rarely receive proper care because of a lack of access to neurological care. In the US, about 40% of those aged 65 or older with PD do not receive care from a neurologist. Access is even more limited in developing regions. Experts suggest an AI-based method to measure Parkinson’s disease severity using a remote finger-tapping test.

Researchers developed a model that uses AI techniques to evaluate motor performance severity of patients. Through performing finger-tapping tasks at home, they analysed the patients with a webcam. A panel of experts and non-experts validated its features, which correlated strongly with the experts’ ratings.

This research shows that remote assessment of the finger-tapping task can be done with reliability. AI models have the potential to perform as well as clinicians and outperform non-specialists in assessing the task, according to the study. The model had an equal performance for all subgroups, suggesting its potential wide adoption in movement disorders.

The tool could enable longitudinal tracking of symptom progression, helping to fine-tune PD treatment. Clinical visits can use it to track PD progression and augment neurologists’ ability to analyze videos with digital biomarkers. In areas with a scarcity of neurologists, the tool could assess symptoms frequently and refer the patient to a neurologist if necessary.

However, the model was not without its limitations. Sometimes, it misclassified severity scores and showed poor accuracy. The model worked well in both high and low-quality videos, making it difficult to evaluate videos taken outside clinical settings. Researchers emphasised ethical considerations as data security, user privacy, and algorithmic bias. When introducing the tool in healthcare settings, these need reviewing.

The researchers also suggest future improvements. These included addressing the impact of tremors on finger-tapping, increasing the sample size, and balancing severity scores as a few improvements to the study.

 

Cover image taken from the research article

Reference url

Recent Posts

Pharmacogenetic Screening
            

Pharmacogenetic Screening: A Cost-Effective Strategy in Treating Major Depressive Disorder

🔍 Discover the cost-effectiveness of pharmacogenetic screening in treating Major Depressive Disorder (MDD).
This approach could save costs and improve patient outcomes in the Spanish National Health System. Read more to understand the potential benefits and future implications. 🌐💡
#SyenzaNews #Pharmacogenetics #MajorDepression #CostEffectiveness #HealthcareInnovation

                 

Healthy Ageing Index and Assessment of Age-Related Outcomes

🌟 Healthy Ageing Index and Assessment of Age-Related Outcomes 🌟

📊 Unlocking the Secrets of Healthy Ageing in Singapore! Discover the significance of the Healthy Ageing Index (HAI) in predicting age-related outcomes! Learn how this tool can help promote healthy ageing and improve quality of life. 👵👴

#SyenzaNews #HealthyAgeing #SingaporeHealthcare #AgeingPopulation #HealthOutcomes

Thailand's healthcare system
              

Thailand’s Healthcare System and the Role of HTA: A Model of Universal Health Coverage

Thailand’s healthcare system is a beacon of efficiency and effectiveness. Achieving Universal Health Coverage in 2002, the country has made remarkable strides in health outcomes, despite spending less compared to other upper-middle-income countries.

Learn how Thailand’s use of Health Technology Assessment (HTA) has played a crucial role in this success and the future steps to address current challenges. 🌍💉

#SyenzaNews #Healthcare #UniversalHealthCoverage #HTA #Innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.